At-Home Telehealth-Supported Subcutaneous Ketamine Therapy for Safety, Feasibility, and Clinical Outcomes in Adults With Moderate to Severe Depression, Anxiety, or Posttraumatic Stress Disorder in a Large, Heterogeneous Cohort in the United States: Retrospective Cohort Study - Quiz - MDSpire

Telehealth-Enabled Subcutaneous Ketamine Treatment at Home: Evaluating Safety, Feasibility, and Clinical Outcomes in Adults with Moderate to Severe Depression, Anxiety, or PTSD in a Diverse U.S. Cohort - A Retrospective Study

  • By

  • Acacia C Parks

  • Amanda L Woodward

  • Robert D Henry

  • Kristin A Arden

  • Leonardo Vando

  • Jack Swain

  • Bishal Lamichhane

  • July 20, 2026

Share

Original Source(s)

At-Home Telehealth-Supported Subcutaneous Ketamine Therapy for Safety, Feasibility, and Clinical Outcomes in Adults With Moderate to Severe Depression, Anxiety, or Posttraumatic Stress Disorder in a Large, Heterogeneous Cohort in the United States: Retrospective Cohort Study

  • by Acacia C Parks, Amanda L Woodward, Robert D Henry, Kristin A Arden, Leonardo Vando, Jack Swain, Bishal Lamichhane

  • July 20, 2026

Related Content

Machine learning-based nomogram for non-suicidal self-injury among depressed adolescents: a multicentre study

Socioeconomic Factors and Health Disparities Among North Korean Refugee Populations

Dynamic frailty and depressive symptoms in relation to incident stroke: findings from five harmonized longitudinal cohorts